NCT07196176 Electrophysiological Registry Duesseldorf
| NCT ID | NCT07196176 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-06-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-06-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry at University Hospital Düsseldorf collects retrospective and prospective (from 2019 onward) data on patients undergoing electrophysiological studies (EPS), catheter ablation, and electrical cardioversion. The primary goal is to evaluate safety, efficacy, and clinical outcomes of these standard procedures in routine care. Data will be used for quality assurance and to identify prognostic patient- and procedure-related factors.
Eligibility Criteria
Inclusion Criteria: * Patients who undergo an electrophysiological study (EPS) or electrical cardioversion at University Hospital Düsseldorf since 2015 (retrospective cohort) * Patients scheduled to undergo an EPS or electrical cardioversion at University Hospital Düsseldorf from 2019 onward (prospective cohort) •- Written informed consent for participation in the registry (prospective part only) Exclusion Criteria: * \< 18 years * Lack of written informed consent * Pregnancy
Contact & Investigator
Malte Kelm, MD
STUDY CHAIR
Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
Frequently Asked Questions
Who can join the NCT07196176 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07196176 currently recruiting?
Yes, NCT07196176 is actively recruiting participants. Contact the research team at obaida.rana@med.uni-duesseldorf.de for enrollment information.
Where is the NCT07196176 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT07196176 clinical trial?
NCT07196176 is sponsored by Heinrich-Heine University, Duesseldorf. The principal investigator is Malte Kelm, MD at Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.